In his new role, Giancola will lead the global organization to gain further market acceptance and continue the growth of Neuromonics. Prior to joining Neuromonics, Giancola was a senior executive with global cochlear implant company, Cochlear Americas, since 1999.
Ron West, chairman of Neuromonics, said: Rick has a proven track record of growing emerging markets for medical device treatments into multi-million dollar businesses. We are confident he has the experience, knowledge and drive to continue Neuromonics growth and help reach our ultimate goal, providing tinnitus sufferers worldwide with the safest and most effective treatment available.